Telecommunications Press Releases
SEE OTHER BRANDS

The latest telecommunications news from the world

Telecommunications Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecommunications Press Releases.

Press releases published on July 28, 2025

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: SUPN) ("Supernus", and the "Company"), today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act …

ParaZero Successfully Completes Field Trial of New Configuration of the DefendAir System, Offering a Comprehensive Counter-Drone Solution

ParaZero Successfully Completes Field Trial of New Configuration of the DefendAir System, Offering a Comprehensive Counter-Drone Solution

Kfar Saba, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospa ce defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) …

Business First Bancshares, Inc., Announces Financial Results for Q2 2025

Business First Bancshares, Inc., Announces Financial Results for Q2 2025

BATON ROUGE, La., July 28, 2025 (GLOBE NEWSWIRE) -- Business First Bancshares, Inc. (NASDAQ: BFST) (Business First), parent company of b1BANK, today announced its unaudited results for the quarter ended June 30, 2025. Business First reported net income …

DatChat Granted Canadian Patent for Advanced Digital Privacy Technology

DatChat Granted Canadian Patent for Advanced Digital Privacy Technology

NEW BRUNSWICK, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- DatChat, Inc. (Nasdaq: DATS) (“DatChat” or the “Company”), a secure messaging and social media company, today announced that the Canadian Patent Office has granted Canadian Patent No. 3,149,004, titled …

Maris-Tech Secures a $144,000 Order from a Customer in the Defense Industry for the Design and Development of Ruggedized AI Platform

Maris-Tech Secures a $144,000 Order from a Customer in the Defense Industry for the Design and Development of Ruggedized AI Platform

The Company will Develop a New Product to Enable Advanced Tactical Video and Edge Computing Capabilities Rehovot, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and …

Concierge Medicine Market Size Worth USD 39.02 Billion by 2034 Amid Demand for Personalized Healthcare

Concierge Medicine Market Size Worth USD 39.02 Billion by 2034 Amid Demand for Personalized Healthcare

Ottawa, July 28, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the concierge medicine market size has been accounted for USD 21.77 billion in 2025 and is predicted to rise from USD 23.23 billion in 2026 to approximately USD 39.02 billion by …

NKGen Biotech Presents Troculeucel Mechanism of Action with Corresponding Phase 1 Biomarker Data at the Alzheimer’s Association International Conference 2025

NKGen Biotech Presents Troculeucel Mechanism of Action with Corresponding Phase 1 Biomarker Data at the Alzheimer’s Association International Conference 2025

Troculeucel, a cryopreserved autologous, non-genetically modified NK cell product, appears to cross the blood brain barrier (BBB) via CXCR3, to reduce neuroinflammation via a simple IV administration. Troculeucel was shown to internalize and digest amyloid …

IMUNON Announces Stock Dividend Boosting Shareholder Value

IMUNON Announces Stock Dividend Boosting Shareholder Value

Stock Dividend Reflects Company’s Confidence in its Phase 3 Study, Long-term Growth Potential, and Dedication to Shareholders LAWRENCEVILLE, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 …

Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025

Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025

Management to host conference call on Thursday, August 7, 2025, at 8:00 am EDT FLORHAM PARK, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel …

ProQR Announces Upcoming Presentation at RNA Editing Summit

ProQR Announces Upcoming Presentation at RNA Editing Summit

LEIDEN, Netherlands …

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Lu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against the 4lg subtype of B7-H3 On track to initiate first-in-human study of RV-01 in solid tumors in 4Q25 SYDNEY, July 28, 2025 (GLOBE NEWSWIRE) -- Radiopharm …

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from July 21, 2025 to July 25, 2025 AMSTERDAM – July 28, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …

Changes in Nokia Corporation's own shares

Changes in Nokia Corporation's own shares

Nokia Corporation Stock Exchange Release 28 July 2025 at 15:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 325 584 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia …

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Nokia Oyj Pörssitiedote 28.7.2025 klo 15.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 325 584 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …

NFI’s MCI awarded expansion order from Metrolinx, strengthening leadership in the commuter coach market

NFI’s MCI awarded expansion order from Metrolinx, strengthening leadership in the commuter coach market

WINNIPEG, Manitoba, July 28, 2025 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leader in propulsion-agnostic bus and coach mobility solutions, subsidiary Motor Coach Industries (MCI), has secured a second order from …

Deliverect Partners with FreedomPay to Transform Payment Operations for Restaurant Chains

Deliverect Partners with FreedomPay to Transform Payment Operations for Restaurant Chains

Philadelphia, PA, July 28, 2025 (GLOBE NEWSWIRE) -- Deliverect, a leading global food tech SaaS company, announces a strategic worldwide partnership with FreedomPay, an innovative leader in Next Level Commerce™. The new partnership will provide white- …

Apyx Medical Corporation Announces Launch of Renuvion® in China

Apyx Medical Corporation Announces Launch of Renuvion® in China

Strong clinical interest and early procedures completed Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance CLEARWATER, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Apyx Medical …

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Increases total holdings to 1,535,772 HYPE Company to host investor webinar on Tuesday, July 29th at 2:00pm ET LAGUNA HILLS, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced …

Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results

Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results

SOMERSET, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Monday, August 11, 2025, to review second-quarter 2025 …

Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025

Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025

NEWTON, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions